 North America Vet Compounding Pharmacies Market Insights, Competitive Landscape, and Market Forecast - 2033
The North America vet compounding pharmacies market is witnessing steady expansion driven by rising demand for personalized veterinary medications. Compounding pharmacies play a critical role in pr... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe North America vet compounding pharmacies market is witnessing steady expansion driven by rising demand for personalized veterinary medications. Compounding pharmacies play a critical role in preparing customized dosages and formulations for animals that cannot be treated effectively with mass-produced drugs. The market is projected to grow from US$ 1.7 Bn in 2026 to US$ 2.9 Bn by 2033, registering a CAGR of 7.80% during the forecast period. Increasing pet ownership, advanced veterinary care, and growing awareness of animal health are key factors shaping the industry landscape. Veterinary professionals increasingly rely on compounding pharmacies to address unique dosage requirements, improve compliance, and enhance therapeutic outcomes across companion and livestock animals.Market Insights: The market is evolving with strong integration of pharmaceutical innovation and veterinary science. North America remains a highly structured market due to advanced healthcare infrastructure and high expenditure on pet healthcare. Compounded medications are increasingly used for pain management, dermatology, hormonal therapies, and chronic disease treatment in animals. The growing preference for flavored and easy-to-administer formulations is further boosting demand. Technological advancements in drug formulation and stringent regulatory oversight are also shaping operational standards across pharmacies. Drivers: Key drivers include rising pet adoption rates, increasing prevalence of chronic diseases among animals, and a growing trend of humanization of pets. Owners are increasingly willing to invest in specialized treatments, fueling demand for customized veterinary drugs. Additionally, shortages of commercially available veterinary drugs are pushing veterinarians toward compounding alternatives. Expanding veterinary clinics and hospital networks also contribute to market growth. Business Opportunity: The market presents strong opportunities for pharmaceutical companies and compounding pharmacies to expand service offerings. Digital prescription platforms and tele-veterinary services are creating new distribution channels. Investments in automated compounding systems and quality assurance technologies can significantly improve efficiency and scalability. Partnerships between veterinarians and compounding pharmacies are expected to increase, creating long-term business growth prospects. Region Analysis: The United States dominates the North America vet compounding pharmacies market due to its large pet population and advanced veterinary healthcare system. Canada is also witnessing steady growth supported by increasing awareness of animal health and supportive regulatory frameworks. Urban regions are particularly driving demand due to higher pet ownership and better access to veterinary services. The region benefits from strong R&D investment and presence of established pharmaceutical companies. Key Players: • Hoye’s Pharmacy • Vertisis Custom Pharmacy • Smith Caldwell Drug Store • Sixth Avenue Medical Pharmacy • Dougherty Pharmacy • Triangle Compounding Pharmacy Inc., • Wedgewood Pharmacy • Millers Pharmacy • Chiron Compounding Pharmacy • MEDS Canadian Compounding Pharmacy Market Segmentation By Product Type : • CNS Agents • Anti-infective Agents • Hormones and Substitutes • Anti-inflammatory Agents • Others By Animal Type : • Companion Animals • Livestock Animals By Formulation : • Oral • Injectable • Others By Region : • North America • Europe • Latin America • East Asia • South Asia and Oceania • Middle East and Africa Table of Contents1. Executive Summary1.1. Global North America Vet Compounding Pharmacies Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033 3.1. Global North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 3.1.1. CNS Agents 3.1.2. Anti-Infective Agents 3.1.3. Hormones and Substitutes 3.1.4. Anti-inflammatory Agents 3.2. Global North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033 3.2.1. Companion Animals 3.2.1.1. Dogs 3.2.1.2. Cats 3.2.1.3. Others 3.2.2. Livestock Animals 3.3. Global North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033 3.3.1. Oral 3.3.2. Injectable 3.3.3. Others 3.4. Global North America Vet Compounding Pharmacies Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033 4.1. North America North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 4.1.1. CNS Agents 4.1.2. Anti-Infective Agents 4.1.3. Hormones and Substitutes 4.1.4. Anti-inflammatory Agents 4.2. North America North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033 4.2.1. Companion Animals 4.2.1.1. Dogs 4.2.1.2. Cats 4.2.1.3. Others 4.2.2. Livestock Animals 4.3. North America North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033 4.3.1. Oral 4.3.2. Injectable 4.3.3. Others 4.4. North America North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.4.1. U.S. North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 4.4.2. U.S. North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 4.4.3. U.S. North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 4.4.4. Canada North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 4.4.5. Canada North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 4.4.6. Canada North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033 5.1. Europe North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 5.1.1. CNS Agents 5.1.2. Anti-Infective Agents 5.1.3. Hormones and Substitutes 5.1.4. Anti-inflammatory Agents 5.2. Europe North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033 5.2.1. Companion Animals 5.2.1.1. Dogs 5.2.1.2. Cats 5.2.1.3. Others 5.2.2. Livestock Animals 5.3. Europe North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033 5.3.1. Oral 5.3.2. Injectable 5.3.3. Others 5.4. Europe North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.4.1. Germany North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.2. Germany North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.3. Germany North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.4.4. Italy North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.5. Italy North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.6. Italy North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.4.7. France North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.8. France North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.9. France North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.4.10. U.K. North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.11. U.K. North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.12. U.K. North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.4.13. Spain North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.14. Spain North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.15. Spain North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.4.16. Russia North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.17. Russia North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.18. Russia North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.4.19. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 5.4.20. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 5.4.21. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033 6.1. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 6.1.1. CNS Agents 6.1.2. Anti-Infective Agents 6.1.3. Hormones and Substitutes 6.1.4. Anti-inflammatory Agents 6.2. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033 6.2.1. Companion Animals 6.2.1.1. Dogs 6.2.1.2. Cats 6.2.1.3. Others 6.2.2. Livestock Animals 6.3. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033 6.3.1. Oral 6.3.2. Injectable 6.3.3. Others 6.4. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.4.1. China North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 6.4.2. China North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 6.4.3. China North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 6.4.4. Japan North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 6.4.5. Japan North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 6.4.6. Japan North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 6.4.7. South Korea North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 6.4.8. South Korea North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 6.4.9. South Korea North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 6.4.10. India North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 6.4.11. India North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 6.4.12. India North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 6.4.13. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 6.4.14. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 6.4.15. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 6.4.16. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 6.4.17. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 6.4.18. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033 7.1. Latin America North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 7.1.1. CNS Agents 7.1.2. Anti-Infective Agents 7.1.3. Hormones and Substitutes 7.1.4. Anti-inflammatory Agents 7.2. Latin America North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033 7.2.1. Companion Animals 7.2.1.1. Dogs 7.2.1.2. Cats 7.2.1.3. Others 7.2.2. Livestock Animals 7.3. Latin America North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033 7.3.1. Oral 7.3.2. Injectable 7.3.3. Others 7.4. Latin America North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.4.1. Brazil North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 7.4.2. Brazil North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 7.4.3. Brazil North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 7.4.4. Mexico North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 7.4.5. Mexico North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 7.4.6. Mexico North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 7.4.7. Argentina North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 7.4.8. Argentina North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 7.4.9. Argentina North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 7.4.10. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 7.4.11. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 7.4.12. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033 8.1. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033 8.1.1. CNS Agents 8.1.2. Anti-Infective Agents 8.1.3. Hormones and Substitutes 8.1.4. Anti-inflammatory Agents 8.2. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033 8.2.1. Companion Animals 8.2.1.1. Dogs 8.2.1.2. Cats 8.2.1.3. Others 8.2.2. Livestock Animals 8.3. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033 8.3.1. Oral 8.3.2. Injectable 8.3.3. Others 8.4. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.4.1. GCC North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 8.4.2. GCC North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 8.4.3. GCC North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 8.4.4. South Africa North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 8.4.5. South Africa North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 8.4.6. South Africa North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 8.4.7. Egypt North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 8.4.8. Egypt North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 8.4.9. Egypt North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 8.4.10. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 8.4.11. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 8.4.12. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 8.4.13. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033 8.4.14. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033 8.4.15. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Hoye’s Pharmacy 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Vertisis Custom Pharmacy 9.4.3. Smith Caldwell Drug Store 9.4.4. Sixth Avenue Medical Pharmacy 9.4.5. Dougherty Pharmacy 9.4.6. Triangle Compounding Pharmacy Inc., 9.4.7. Wedgewood Pharmacy 9.4.8. Millers Pharmacy 9.4.9. Chiron Compounding Pharmacy 9.4.10. MEDS Canadian Compounding Pharmacy 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の 医薬品・バイオテクノロジー分野 での最新刊レポート
本レポートと同じKEY WORD（pharmacies）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
